The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer

Zahraa Al-Hilli, Judy C Boughey

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Neoadjuvant chemotherapy (NAC) has traditionally been used in locally advanced and inflammatory breast cancer, allowing for a reduction in disease volume and therefore optimizing surgical resection of disease in the breast. NAC impacts both the tumor in the breast and the lymph nodes and may allow for the option of breast-conserving surgery and avoiding an axillary dissection. The aim of this review is to discuss the considerations and timing of surgical treatment of the breast and the axilla following NAC in patients with breast cancer.

Original languageEnglish (US)
Article number37
JournalChinese Clinical Oncology
Volume5
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Breast
Breast Neoplasms
Drug Therapy
Inflammatory Breast Neoplasms
Breast Diseases
Axilla
Segmental Mastectomy
Dissection
Lymph Nodes
Therapeutics

Keywords

  • Breast cancer
  • Neoadjuvant chemotherapy (NAC)

ASJC Scopus subject areas

  • Oncology

Cite this

The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer. / Al-Hilli, Zahraa; Boughey, Judy C.

In: Chinese Clinical Oncology, Vol. 5, No. 3, 37, 2016.

Research output: Contribution to journalReview article

@article{d8b07ec5bd8240d192c639b1484a562c,
title = "The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer",
abstract = "Neoadjuvant chemotherapy (NAC) has traditionally been used in locally advanced and inflammatory breast cancer, allowing for a reduction in disease volume and therefore optimizing surgical resection of disease in the breast. NAC impacts both the tumor in the breast and the lymph nodes and may allow for the option of breast-conserving surgery and avoiding an axillary dissection. The aim of this review is to discuss the considerations and timing of surgical treatment of the breast and the axilla following NAC in patients with breast cancer.",
keywords = "Breast cancer, Neoadjuvant chemotherapy (NAC)",
author = "Zahraa Al-Hilli and Boughey, {Judy C}",
year = "2016",
doi = "10.21037/cco.2016.03.26",
language = "English (US)",
volume = "5",
journal = "Chinese Clinical Oncology",
issn = "2304-3865",
publisher = "Society for Translational Medicine (STM)",
number = "3",

}

TY - JOUR

T1 - The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer

AU - Al-Hilli, Zahraa

AU - Boughey, Judy C

PY - 2016

Y1 - 2016

N2 - Neoadjuvant chemotherapy (NAC) has traditionally been used in locally advanced and inflammatory breast cancer, allowing for a reduction in disease volume and therefore optimizing surgical resection of disease in the breast. NAC impacts both the tumor in the breast and the lymph nodes and may allow for the option of breast-conserving surgery and avoiding an axillary dissection. The aim of this review is to discuss the considerations and timing of surgical treatment of the breast and the axilla following NAC in patients with breast cancer.

AB - Neoadjuvant chemotherapy (NAC) has traditionally been used in locally advanced and inflammatory breast cancer, allowing for a reduction in disease volume and therefore optimizing surgical resection of disease in the breast. NAC impacts both the tumor in the breast and the lymph nodes and may allow for the option of breast-conserving surgery and avoiding an axillary dissection. The aim of this review is to discuss the considerations and timing of surgical treatment of the breast and the axilla following NAC in patients with breast cancer.

KW - Breast cancer

KW - Neoadjuvant chemotherapy (NAC)

UR - http://www.scopus.com/inward/record.url?scp=84973508309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973508309&partnerID=8YFLogxK

U2 - 10.21037/cco.2016.03.26

DO - 10.21037/cco.2016.03.26

M3 - Review article

VL - 5

JO - Chinese Clinical Oncology

JF - Chinese Clinical Oncology

SN - 2304-3865

IS - 3

M1 - 37

ER -